Sort
261,768 grants matching “gene therapy”
Cytopathology Core
$1,885,778Armando Filie · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
New Targets for Therapy for Adenocarcinoma of the Lung
$1,885,662Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Roles and Regulation of wild-type and mutant forms of p53
$1,885,586Carol Prives · Columbia Univ New York Morningside · P01 · FY2020 · CA
Roles and Regulation of wild-type and mutant forms of p53
$1,885,586Carol Prives · Columbia Univ New York Morningside · P01 · FY2021 · CA
HIV persistence in vivo
$1,885,466Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Innate and Adaptive Immunity in Parkinson Disease
$1,885,412David G Standaert · University Of Alabama At Birmingham · P50 · FY2021 · NS
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,885,349Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Gene Therapy for Cystic Fibrosis
$1,885,047Richard J Samulski · Univ Of North Carolina Chapel Hill · P01 · FY2006 · HL
GENE THERAPY FOR SICKLE CELL ANEMIA
$1,884,934Yeshiva University · P01 · FY2002 · HL
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,884,922Joseph J Cullen · University Of Iowa · P01 · FY2019 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,884,842Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
NORMAL & NEOPLASTIC GROWTH IN THE BRAIN
$1,884,764Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2021 · CA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,884,362Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Cell Identity and Signaling (CIS)
$1,884,000Ourania M. Andrisani · Purdue University · P30 · FY2025 · CA
Processing and Repair of DNA Crosslinks
$1,883,919Richard D Wood · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$1,883,865Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
$1,883,865Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
SPECIALIZED CENTER OF RESEARCH IN ISCHEMIC HEART DISEASE
$1,883,759Tufts Medical Center · P50 · FY2000 · HL
Gene Regulatory Events in Establishing Mature T Cell Tolerance
$1,883,613Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of Novel Therapies for NIDDM
$1,883,574Christopher B Newgard · Duke University · P01 · FY2009 · DK
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,883,308E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$1,883,039Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Gene Therapy Approaches for Primary Immunodeficiencies
$1,882,685Fabio Candotti · Human Genome Research · Z01 · FY2007 · HG
Integrating genome-wide association study data with single-cell `omics' to reveal the cellular effectors of glioblastoma predisposition
$1,882,680Quinn T Ostrom · Duke University · R01 · FY2025 · CA
Gene Therapy Using Hematopoietic Stem Cells
$1,881,963Donald B Kohn · University Of California Los Angeles · P01 · FY2009 · HL